Cited by 344Virus-based gene therapy researchRNA Interference and Gene DeliveryViral Infectious Diseases and Gene Expression in Insects

The DOI matches its Crossref record; 34 of the 36 references it cites were found in a registry or an index.

Helper virus-free, optically controllable, and two-plasmid-based production of adeno-associated virus vectors of serotypes 1 to 6

Open access

Grimm, Dirk, Kay, Mark A, Kleinschmidt, Juergen A·2003·Molecular Therapy

DOI 10.1016/s1525-0016(03)00095-9

Open this paper in CoChat — free account Open PDF

Abstract

We present a simple and safe strategy for producing high-titer adeno-associated virus (AAV) vectors derived from six different AAV serotypes (AAV-1 to AAV-6). The method, referred to as "HOT," is helper virus free, optically controllable, and based on transfection of only two plasmids, i.e., an AAV vector construct and one of six novel AAV helper plasmids. The latter were engineered to carry AAV serotype rep and cap genes together with adenoviral helper functions, as well as unique fluorescent protein expression cassettes, allowing confirmation of successful transfection and identification of the transfected plasmid. Cross-packaging of vector DNA derived from AAV-2, -3, or -6 was up to 10-fold more efficient using our novel plasmids, compared to a conservative adenovirus-dependent method. We also identified a variety of useful antibodies, allowing detection of Rep or VP proteins, or assembled capsids, of all six AAV serotypes. Finally, we describe unique cell tropisms and kinetics of transgene expression for AAV serotype vectors in primary or transformed cells from four different species. In sum, the HOT strategy and the antibodies presented here, together with the reported findings, should facilitate and support the further development of AAV serotype vectors as powerful new tools for human gene therapy.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/s1525-0016(03)00095-9

Cites

34 of 34 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy
Gao, G.-P., Alvira, M. R., Wang, L., Calcedo, R., Johnston, J., & Wilson, J. M. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.182412299 · Cited by 1,520
Membrane-Associated Heparan Sulfate Proteoglycan Is a Receptor for Adeno-Associated Virus Type 2 Virions
Summerford, C., & Samulski, R. J. (1998) · Journal of Virology · doi:10.1128/jvi.72.2.1438-1445.1998 · Cited by 1,409
Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield
Zolotukhin, S., Byrne, B. J., Mason, E. G., Zolotukhin, I., Potter, M., Chesnut, K. A., Summerford, C., Samulski, R. J., & Muzyczka, N. (1999) · Gene Therapy · doi:10.1038/sj.gt.3300938 · Cited by 1,321
Evidence for gene transfer and expression of factor IX in haemophilia B patients treated with an AAV vector
Kay, M. A., Manno, C. S., Ragni, M. V., Larson, P. J., Couto, L. B., McClelland, A., Glader, B. E., Chew, A. K., Tai, S. J., Herzog, R. W., et al. (2000) · Nature Genetics · doi:10.1038/73464 · Cited by 1,019
Self-citation
Cross-Packaging of a Single Adeno-Associated Virus (AAV) Type 2 Vector Genome into Multiple AAV Serotypes Enables Transduction with Broad Specificity
Rabinowitz, J. E., Rolling, F., Li, C., Conrath, H., Xiao, W., Xiao, X., & Samulski, R. J. (2002) · Journal of Virology · doi:10.1128/jvi.76.2.791-801.2002 · Cited by 762
Novel Tools for Production and Purification of Recombinant Adenoassociated Virus Vectors
Grimm, D., Kern, A., Rittner, K., & Kleinschmidt, J. A. (1998) · Human Gene Therapy · doi:10.1089/hum.1998.9.18-2745 · Cited by 701
Self-citation
A "humanized" green fluorescent protein cDNA adapted for high-level expression in mammalian cells
Zolotukhin, S., Potter, M., Hauswirth, W. W., Guy, J., & Muzyczka, N. (1996) · Journal of Virology · doi:10.1128/jvi.70.7.4646-4654.1996 · Cited by 609
Gene therapy vectors based on adeno-associated virus type 1
Xiao, W., Chirmule, N., Berta, S. C., McCullough, B., Gao, G., & Wilson, J. M. (1999) · Journal of Virology · doi:10.1128/jvi.73.5.3994-4003.1999 · Cited by 541
Recombinant adeno-associated virus type 2, 4, and 5 vectors: Transduction of variant cell types and regions in the mammalian central nervous system
Davidson, B. L., Stein, C. S., Heth, J. A., Martins, I., Kotin, R. M., Derksen, T. A., Zabner, J., Ghodsi, A., & Chiorini, J. A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.7.3428 · Cited by 531
Current protocols in human genetics
Bates, G. P. (1995) · Trends in Genetics · doi:10.1016/s0168-9525(00)89147-7 · Cited by 484

Show all 36 references

Sorted by citations

Items 301–344 of 344

Correction of Feline Lipoprotein Lipase Deficiency with Adeno-Associated Virus Serotype 1-Mediated Gene Transfer of the Lipoprotein Lipase S447X Beneficial Mutation
Ross, C. J., Twisk, J., Bakker, A. C., Miao, F., Verbart, D. J., Rip, J., Godbey, T., Dijkhuizen, P. A., Hermens, W. T. J. M. C., Kastelein, J. J. P., et al. (2006) · Human Gene Therapy · doi:10.1089/hum.2006.17.ft-198 · Cited by 2
Neuropeptide delivery to the brain: a von Willebrand factor signal peptide to direct neuropeptide secretion
de Backer, M. W. A., Brans, M. A. D., Luijendijk, M. C. M., Garner, K. M., van den Heuvel, D. M. A., Pasterkamp, R. J., & Adan, R. A. H. (2010) · BMC Neuroscience · doi:10.1186/1471-2202-11-94 · Cited by 1
The Use of Viral Vectors to Enhance Cognition
Ikezu, T. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-417042-1.00006-1 · Cited by 1
Systemic Gene Delivery for Muscle Gene Therapy
Garikipati, D. K., & Chamberlain, J. S. (2009) · Springer eBooks · doi:10.1007/978-1-4419-1207-7_10 · Cited by 1
Effect of amisulpride on the expression of serotonin receptors, neurotrophic factor BDNF and its receptors in mice with overexpression of the aggregation-prone [R406W] mutant tau protein
Kondaurova, E. M., Komarova, A. A., Ilchibaeva, T. V., Rodnyy, A. Y., Zalivina, E. A., & Naumenko, V. S. (2024) · Vavilov Journal of Genetics and Breeding · doi:10.18699/vjgb-24-45 · Cited by 1
AAV‐Mediated Expression of Methamphetamine Monoclonal Antibody Attenuates Methamphetamine Behaviour Sensitization in Mice
Chen, Y., Hung, T., Wang, Y.-S., Bae, E., Wu, K., Wang, Y., & Yu, S. (2025) · Addiction Biology · doi:10.1111/adb.70073 · Cited by 1
Adeno-Associated Virus Vectors for Gene Therapy: From Scalable Production Systems via Serotype-Specific Glycan Interaction Patterns to Gene Transfer Applications
Mietzsch, M. (2014) · Cited by 1
AAV Capsid Screening for Translational Pig Research Using a Mouse Xenograft Liver ModelPreprint
Willimann, M., Tiyaboonchai, A., Adachi, K., Li, B., Waldburger, L., Nakai, H., Grompe, M., & Thöny, B. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.05.29.596409 · Cited by 1
On the Neurobiology of Physical Activity in Mice and Human : In search of Eating Disorders Determinants
Kostrzewa, E. (2014) · Utrecht University Repository (Utrecht University)
Apolipoproteins A-I and A-V as gene therapeutic targets to intervene in lipid metabolism
Vaessen, S. F. C. (2009) · UvA-DARE (University of Amsterdam)
Use of Gene Transfer to Study HDL Remodeling
Oka, K., & Chan, L. (2007) · Wiley eBooks · doi:10.1002/9783527625178.ch9
Laser-evoked synaptic transmission in cultured hippocampal neurons channelrhodopsin-2 delivered by adeno-associated virus
Wang, J. P., Hasan, M. T., & Seung, H. S. (2009) · DSpace@MIT (Massachusetts Institute of Technology)
Lipoprotein lipase, hypertriglyceridemia and atherosclerosis
Rip, J. (2006) · UvA-DARE (University of Amsterdam)
Charakterisierung der Proteinphosphatase 1E (PPM1E) - Lokalisierung und Trunkation in Gehirngewebe und Effekte auf neuronale Morphologie in primärer Neuronenkultur
Jessen, A. L. (2010) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-406
Development of a Ribozyme Gene Therapy Against Herpes Simplex Virus Type I (HSV-1) Infection
Liu, J., Bloom, D. C., Lewin, A. S., Tuli, S. S., Ghivizzani, S. C., & Schultz, G. S. (2007) · Investigative Ophthalmology & Visual Science
Understanding the Mechanisms of Action of Hypercapnic Acidosis and the Therapeutic Potential of Human Mesenchymal Stromal Cells in Diminishing Inflammation and Enhancing Repair in Acute Respiratory Distress Syndrome.
Masterson, C. H. (2013) · Arrow@dit (Dublin Institute of Technology) · doi:10.13025/16476
Toward a Recombinant Adeno-Associated Virus Origin of Replication
Hewitt, F. C. (2009) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/52hj-6c04
Myokardialer Gentransfer mittels Adenoassoziierter Viraler Vektoren
Steinbeck, G. (2012)
Engineering delivery and release of protein therapeutics for mammalian systems
Fluri, D. A. (2008) · Repository for Publications and Research Data (ETH Zurich) · doi:10.3929/ethz-a-005708602
Novel strategies to improve viral gene targeting and therapeutic liver repopulation in vivo
Paulk, N. K. (2012) · doi:10.6083/m4k935jk
Viral Vectors for Delivering Gene Material into Cells and Their Application in Neurobiology (Review)
Epifanova, E. A., Borisova, E. V., Salina, V. A., & Babaev, A. A. (2017) · Современные технологии в медицине · doi:10.17691/stm2017.9.1.21
DETERMINANTS OF AAV TRANSPORT ACROSS THE BLOOD-BRAIN BARRIER
Albright, B. H. (2018) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/vnpr-wx33
Amelioration of Arthritis by Intraarticular Dominant Negative IKK Gene Therapy Using Adeno-Associated Virus Type 5
Tas, S. W., Adriaansen, J., Hajji, N., Bakker, A. C., Firestein, G. S., Vervoordeldonk, M. J., & Tak, P. P. (2006) · Human Gene Therapy · doi:10.1089/hum.2006.17.ft-228
Transmembrane Channel-Like (Tmc) Gene Therapy Restores Auditory Function in Deaf Mice
Askew, C. (2015) · doi:10.18130/v3825c
Transduction Technologies
Fluri, D. A., & Fussenegger, M. (2007) · Methods in biotechnology · doi:10.1007/978-1-59745-399-8_1
Faculty Opinions recommendation of ORANGE: A CRISPR/Cas9-based genome editing toolbox for epitope tagging of endogenous proteins in neurons.
Moine, H. (2020) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.737719242.793575501
Capsid modifications of adeno-associated virus serotype 2
(2022) · International Multiconference on Bioinformatics of Genome Regulation and Structure / Systems Biology (BGRS/SB) · doi:10.18699/bgrs/sb-2022-047
Capsid modifications of adeno-associated virus serotype 2
(2022) · International Multiconference on Bioinformatics of Genome Regulation and Structure / Systems Biology (BGRS/SB) · doi:10.18699/sbb-2022-047
Living on the edge
Scheefhals, N. (2022) · Utrecht University Repository (Utrecht University) · doi:10.33540/1224
Ongoing neuronal population activity dynamics in the neocortex - representational drift in experiment and model
Eppler, J.-B. (2022) · Publication Server of Goethe University Frankfurt am Main (Goethe University Frankfurt) · doi:10.21248/gups.69221
Biomanufacturing Aspects of Gene Therapy
Warnock, J. N. (2023) · Cell engineering · doi:10.1007/978-3-031-45669-5_14
The Development of Signs of Alzheimer’s Disease in OXYS Rats is Accompanied by a Decrease in the Expression of Cerebral Dopamine Neurotrophic Factor (CDNF), and is not Compensated by Its Overexpression
Kaminskaya, Y. P., Ilchibaeva, T. V., Kozlova, T. A., Kolosova, N. G., Naumenko, V. S., & Tsybko, A. S. (2024) · Нейрохимия · doi:10.31857/s1027813324040085
The Development of Signs of Alzheimer’s Disease in OXYS Rats Is Accompanied by a Decrease in the Expression of Cerebral Dopamine Neurotrophic Factor (CDNF) and Is Not Compensated by Its Overexpression
Kaminskaya, Y. P., Ilchibaeva, T. V., Kozlova, T. A., Kolosova, N. G., Naumenko, V. S., & Tsybko, A. S. (2024) · Neurochemical Journal · doi:10.1134/s1819712424700351
Sustained high expression of human FVII following AAV8-mediated gene delivery in mice
D’Amico, A., Blits, B., van den Herik, J., de Winter, F., Kaijen, P. H. P., Hobo, B., van Asbeck, A. H., Verhaagen, J., Mosmuller, D. G. M., & Voorberg, J. (2025) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2025.101523
Overexpression of Cerebral Dopamine Neurotrophic Factor (CDNF) in the Hippocampus Enhances Social Interest in C57BL/6J Mice
Eremin, D. V., Kaminskaya, Y. P., Ilchibaeva, T. V., Naumenko, V. S., & Tsybko, A. S. (2025) · Neurochemical Journal · doi:10.1134/s1819712425700424
Effects of 5-HT1A Receptor Overexpression in the Frontal Cortex on Autism-Like Behavior and the Expression of 5-HT1A and 5-HT7 Receptors and BDNF in BTBR Mice
Kondaurova, E. M., Григорьева, Ю. Д., Belokopytova, I. I., Kulikova, E. A., Tsybko, A. S., Хоцкин, Н. В., Ilchibaeva, T. V., Popova, N. K., & Naumenko, V. S. (2025) · Neurochemical Journal · doi:10.1134/s1819712425700400
Systemic Interplay of BDNF and Serotonin Pathways Defines Behavioral and Molecular Responses to Midbrain 5-HT7 Overexpression and Chronic Ethanol Consumption
Rodnyy, A. Y., Орешко, А. С., Eremin, D. V., Naumenko, V. S., & Базовкина, Д. В. (2026) · Biomolecules · doi:10.3390/biom16010106
Mécanismes de neurodégénérescence associés au processus inflammatoire dans la sclérose latérale amyotrophique
Aebischer, J. (2011) · theses.fr (ABES) · doi:10.70675/7dc30612zb4b4z49a3z864bz8fa2e995aa0e
Développement de nouveaux modèles expérimentaux de la Sclérose Latérale Amyotrophique
Langou, K. (2010) · theses.fr (ABES) · doi:10.70675/b77c5438zccd7z4f8bz935az7ab30698b8a8
Characterization of rAAV vectors packaging in baculovirusinfected insect cells
Penaud‐Budloo, M. (2018) · theses.fr (ABES) · doi:10.70675/c5cff6daz8fe4z430cz80e6z97a11cc59c8e
Vers la modification et l’assemblage de novo du génome baculoviral en vue de la production de vecteurs AAV
Fontaine, M. B. (2017) · doi:10.70675/19f021abze152z4dd1za271z715352e2629c
Selector adeno-associated viral vectors facilitate on-target precise genome editing and purge off-target chromosomal insertions
Li, Z., Wang, X., Liu, J., Janssen, J. M., Hoeben, R. C., & Gonçalves, M. A. F. V. (2026) · Trends in biotechnology · doi:10.1016/j.tibtech.2026.01.006
AAV-DJ enables efficient, function-preserving neuronal transduction for circuit interrogation in human cortical and thalamic organoids
Adachi, S., Nishimura, M., Yamaguchi, K., Ano, S. A. T. O., Takeuchi, R. F., & Osakada, F. (2026) · Cell Reports Methods · doi:10.1016/j.crmeth.2026.101546
Combined Plasmid Redesign and Transfection Optimization Significantly Increases Upstream AAV Titers While Maintaining Vector Quality and In Vivo Potency
Hu, S., Chen, Y., Wu, C., Reuter, W. H., Deng, J., Jia, N., Walsh, N., Bastille, A., Edwards, T. M. E., Hebben, M., et al. (2026) · Microorganisms · doi:10.3390/microorganisms14081857

Authors: Grimm, D., Kay, M. A., & Kleinschmidt, J. A.
Affiliations: Stanford Medicine (US)
German Cancer Research Center (DE)
Corresponding author: Kay, Mark A
ORCID: Grimm, Dirk
Kay, Mark A
Venue: Molecular Therapy
Publisher: Elsevier BV
Published: 2003-06
Volume: 7
Issue: 6
Pages: 839-850
ISSN: 1525-0016 (ISSN-L)
DOI: 10.1016/s1525-0016(03)00095-9
OpenAlex: W1977797303
Cited by: 344
References: 36
Citations by year: 2026: 4 · 2025: 9 · 2024: 12 · 2023: 10 · 2022: 15 · 2021: 17 · 2020: 12 · 2019: 18 · 2018: 5 · 2017: 17 · 2016: 7 · 2015: 21 · 2014: 12 · 2013: 20 · 2012: 19
FWCI: 7.96
Type: journal article
Language: en
Open access: hybrid
doi.org
Licence: cc-by-nc-nd
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
creativecommons.org/licenses/by-nc-nd/4.0/ (vor, 4877 d)
Locations: Molecular Therapy (publishedVersion, cc-by-nc-nd)
PubMed (publishedVersion)
Funders: National Heart, Lung, and Blood Institute (HL66948, U01HL066948)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Viral Infectious Diseases and Gene Expression in Insects
Keywords: adeno-associated virus vectors, fluorescent protein markers, cell tropism, transgene expression kinetics, gene therapy vectors
MeSH terms: Dependovirus, Cell Line, DNA Replication, DNA-Binding Proteins, Genetic Vectors, Helper Viruses, Humans, Plasmids, Serotyping, Viral Proteins, Virus Replication, Virus Assembly

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Helper virus-free, optically controllable, and two-plasmid-based production of adeno-associated virus vectors of serotypes 1 to 6

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks